CAR-T Technology(Shanxi Bethune Hospital)

N/A

Report date: 2024/02/05 20:04:22

Base Information

Drug NameCAR-T Technology(Shanxi Bethune Hospital)

Drug Alias NameCAR-T cell therapy(Shanxi Bethune Hospital)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesShanxi Bethune Hospital

China Registration ClassN/A

Develop Information

Active CompaniesShanxi Bethune Hospital

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A